Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral sotalol versus metoprolol succinate for prevention of atrial fibrillation after CABG
IRCT20231123060154N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sotalol and metoprolol in Atrial fibrillation (AFib) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Incidence of atrial fibrillation. Started Dec 2023; status: completed.
02
Drugs
sotalolmetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20231123060154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231123060154N1.